No

Mast Cell Stabilizer

Treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis

B

Hypersensitivity to any component of product

Safety and efficacy in children <2 years of age have not been established; not for injection; not for use in patients wearing soft contact lenses during treatment

>10%: Local: Transient burning, stinging, discomfort

1% to 10%:

Central nervous system: Headache

Ocular: Blurred vision, corneal erosion/ulcer, eye pain, corneal abrasion, blepharitis

<1%: Dizziness, somnolence, rash, nausea, stomach discomfort, sneezing, dry nose

Symptoms include feeling of warmth of flushing, headache, dizziness, fatigue, sweating, nausea, loose stools, and urinary frequency/urgency; consider emesis in the event of accidental ingestion

No data reported

Mast cell stabilizer that inhibits the in vivo type I immediate hypersensitivity reaction to increase cutaneous vascular permeability associated with IgE and antigen-mediated reactions

Absorption: Topical: Very small and undetectable

Children >2 years and Adults: Instill 1-2 drops in eye(s) 4 times/day for up to 3 months

May cause drowsiness or dizziness

None reported

No information available to require special precautions

No effects or complications reported

Do not wear soft contact lenses during treatment

Solution, ophthalmic: 0.1% (10 mL)